EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Identification and functional validation of a novel disease‐causing variant in the noncoding region of NYX

Filip Spanic iD, Christelle Michiels iD, Julien Navarro, Aline Antonio, Christel Condroyer iD, Camille Andrieu, Billy Gipsy, Sylvie Berthémy-Pellet, Mathilde Gallice iD, Isabelle Audo iD, Christina Zeitz iD

Acta Ophthalmologica · 2026-08 · 104 (5)

DOI: 10.1111/aos.70094 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Acta Ophthalmologica, online erschienen am 23.02.2026. Verfasst von Filip Spanic und 10 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France. Hauptthemen laut MEDLINE: Night Blindness, Eye Diseases, Hereditary, Myopia, Genetic Diseases, X-Linked. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche within the Investissements d'Avenir, LABEX LIFESENSES, Foundation Fighting Blindness Center grant CCMM-0907-0428-INSERM04 and BR-GE-0619-0761-INSERM.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Inherited retinal diseases (IRDs) are a clinically and genetically heterogeneous group of disorders, with ~30% of cases remaining genetically unsolved. Complete congenital stationary night blindness (cCSNB) is a subtype of IRD, usually associated with reduced visual acuity, nystagmus and high myopia. Most cases are caused by variants in NYX , TRPM1 , GRM6 , GPR179 or LRIT3 . This study aimed to identify the genetic defect in a subject with clinically diagnosed cCSNB lacking coding variants in known associated genes.

Methods

A male patient presented with an electroretinogram profile consistent with cCSNB in the absence of high myopia. Pathogenic variants were not detected using Sanger sequencing of the coding regions of all known CSNB‐associated genes. Whole genome sequencing (WGS) and bioinformatic analysis using SpliceAI, Pangolin, REVEL, CADD v1.7, BayesDel and MetaRNN were performed to detect potential pathogenic variants. Functional impact of this variant has been analysed using LINSIGHT, ReMM and FunUV. A minigene assay was used to assess the splicing impact of the identified variant.

Results

WGS identified a novel c.‐57G>A variant in the 5′ untranslated region, within exon 1 of NYX coding for nyctalopin. In silico predictions suggested this variant to alter splicing, which was confirmed by a minigene assay showing abnormal expression of NYX . The defect was predicted to reduce nyctalopin production, potentially explaining the milder cCSNB phenotype.

Conclusions

To our knowledge, this is the first report describing a noncoding variant in NYX causing CSNB but lacking high myopia. These results highlight the clinical importance of screening noncoding regions of known IRD genes in genetically unsolved cases. Whether the development of high myopia in cCSNB depends on the type and location of NYX variants remains to be elucidated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Night BlindnessEye Diseases, HereditaryMyopiaGenetic Diseases, X-LinkedMembrane ProteinsMyopia, DegenerativeMutationDNAHumansMaleDNA Mutational AnalysisElectroretinographyPedigreeWhole Genome SequencingProteoglycans

Stichwörter der Autor:innen

NYXcCSNBhigh myopianoncoding variantsplice‐site mutation

Substanzen

NYX protein, humanMembrane ProteinsDNAProteoglycans

Autor:innen und Institutionen

  • Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
  • Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Centre de Référence Maladies Rares REFERET and INSERM-DGOS CIC 1423, Paris, France.
  • Centre de Référence Anomalie du développement Service de génétique CHUGA - Hôpital Couple Enfant, Grenoble, France.
  • Department of Ophthalmology, University of Grenoble, Grenoble, France.

ORCID-Profile: Filip Spanic, Christelle Michiels, Christel Condroyer, Mathilde Gallice, Isabelle Audo, Christina Zeitz

Förderung

  • Agence Nationale de la Recherche within the Investissements d'Avenir
  • LABEX LIFESENSES
  • Foundation Fighting Blindness Center grant CCMM-0907-0428-INSERM04 and BR-GE-0619-0761-INSERM
  • 10.13039/100018694-HORIZON EUROPE Marie Sklodowska-Curie Actions
  • Fondation Voir et Entendre
  • IHU FOReSIGHT

Zitieren

APA

Spanic, F., Michiels, C., Navarro, J., Antonio, A., Condroyer, C., Andrieu, C., Gipsy, B., Berthémy-Pellet, S., Gallice, M., Audo, I., & Zeitz, C. (2026). Identification and functional validation of a novel disease‐causing variant in the noncoding region of NYX. Acta Ophthalmologica, 104(5). https://doi.org/10.1111/aos.70094

Vancouver

Spanic F, Michiels C, Navarro J, Antonio A, Condroyer C, Andrieu C, et al. Identification and functional validation of a novel disease‐causing variant in the noncoding region of NYX. Acta Ophthalmologica. 2026;104(5). doi:10.1111/aos.70094

BibTeX
@article{Spanic2026,
  author = {Spanic, Filip and Michiels, Christelle and Navarro, Julien and Antonio, Aline and Condroyer, Christel and Andrieu, Camille and Gipsy, Billy and Berthémy-Pellet, Sylvie and Gallice, Mathilde and Audo, Isabelle and Zeitz, Christina},
  title = {Identification and functional validation of a novel disease‐causing variant in the noncoding region of NYX},
  journal = {Acta Ophthalmologica},
  year = {2026},
  volume = {104},
  number = {5},
  doi = {10.1111/aos.70094}
}
Kostenlos starten →